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Short bowel syndrome (SBS) results from significant loss of small intestinal length. In
response to this loss, adaptation occurs, with Epidermal Growth Factor Receptor (EGFR)
being a key driver. Besides enhanced enterocyte proliferation, we have revealed that adap-
tation is associated with angiogenesis. Further, we have found that small bowel resection
(SBR) is associated with diminished oxygen delivery and elevated levels of hypoxia-induc-
ible factor 1-alpha (HIF1α).
Methods
We ablated EGFR in the epithelium and endothelium as well as HIF1α in the epithelium,
ostensibly the most hypoxic element. Using these mice, we determined the effects of these
genetic manipulations on intestinal blood flow after SBR using photoacoustic microscopy
(PAM), intestinal adaptation and angiogenic responses. Then, given that endothelial cells
require a stromal support cell for efficient vascularization, we ablated EGFR expression in
intestinal subepithelial myofibroblasts (ISEMFs) to determine its effects on angiogenesis in
a microfluidic model of human small intestine.
Results
Despite immediate increased demand in oxygen extraction fraction measured by PAM in all
mouse lines, were no differences in enterocyte and endothelial cell EGFR knockouts or
enterocyte HIF1α knockouts by POD3. Submucosal capillary density was also unchanged
by POD7 in all mouse lines. Additionally, EGFR silencing in ISEMFs did not impact vascular
network development in a microfluidic device of human small intestine.
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Conclusions
Overall, despite the importance of EGFR in facilitating intestinal adaptation after SBR, it had
no impact on angiogenesis in three cell types–enterocytes, endothelial cells, and ISEMFs.
Epithelial ablation of HIF1α also had no impact on angiogenesis in the setting of SBS.
Introduction
Short bowel syndrome (SBS) results from extensive surgical loss of small intestine (SI), resulting
in severely diminished absorptive capacity and the inability to meet nutritional demands. Inci-
dence of SBS drastically increases in preterm infants compared to full term infants, reported at
353.7 compared to 3.5 per 100,000 live births, respectively[1]. In addition to a 27% mortality
rate, SBS has significant morbidity, associated with the need for prolonged parenteral nutrition
leading to catheter-associated sepsis and intestinal failure associated liver disease[2–5].
Following massive small bowel resection (SBR), the remaining SI undergoes adaptation, a
critical compensatory process characterized by increased enterocyte proliferation leading to
villus lengthening and crypt deepening. This expands mucosal surface area for nutrient
absorption[6, 7]. If the remnant SI fails to adapt, patients require parenteral nutrition, which is
associated with its own added morbidity[8].
In addition to enhanced enterocyte proliferation, intestinal adaptation after SBR is associ-
ated with new blood vessel growth (angiogenesis) within the intestinal villi and submucosal
layers[9, 10]. This proliferation of new vessels from a preexisting vascular bed allows for
enhanced influx of nutrients, growth factors, oxygen, and immune cells, to stimulate repair
and growth[11, 12]. Resection-associated angiogenesis may play a role in maintaining mucosal
integrity and increasing absorptive capacity, both of which are important in the setting of SBS.
Additionally, increased microvascular flow may enhance absorptive capacity in patients with
SBS[13]. On the other hand, villus hypoperfusion is associated with disrupted mucosal integ-
rity and sets the stage for bacterial translocation and sepsis[14, 15].
Using photoacoustic microscopy (PAM), we previously identified a significant fall in oxy-
gen saturation and blood flow within the remnant SI within minutes after SBR in vivo. This
suggests that resection-associated angiogenesis may be triggered by an initial hypoxic signal
[16]. Hypoxia-inducible factor 1-alpha (HIF1α) is a major mediator of hypoxia-induced angio-
genesis, and has been shown to be elevated following SBR[17]. HIF1α is stimulated not only by
hypoxia, but also by proinflammatory microenvironments, and by stimulus of certain growth
factor receptors[18]. One example of this is Epidermal Growth Factor Receptor (EGFR)[19–
21]. A link between EGFR and HIF1α signaling has been established in a prototypical intesti-
nal epithelial cell line, with Epidermal Growth Factor (EGF) providing HIF1α stabilization
[22]. And, whereas EGFR can induce the accumulation of HIF, HIF signaling has also been
shown to activate EGFR signaling[23, 24].
Following SBR, there is a significant increase in the expression and activity of intestinal
EGFR (including epithelial and subepithelial EGFR), which has been shown to contribute to
adaptation. Interestingly, however, epithelial-specific EGFR was found to be dispensable for
structural adaptation[25–28]. In that study, we did not examine the angiogenic response to
epithelial EGFR knockout. Our prior findings did lead us to speculate that EGFR signaling in
the subepithelium may be just as if notmore critical than epithelial EGFR signaling during
adaptation. As such, our hypothesis for this study is that subepithelial EGFR signaling drives
resection-associated angiogenesis.
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The subepithelium contains numerous cell types including nerves, blood vessels with associ-
ated endothelial cells (ECs), lymphatics, immune cells, and stromal cells. Unlike intestinal epithe-
lium (unique in its expression of the Villin promotor), organ-specific knockouts of these tissue
components are not feasible. Rather, any gene knockout in these tissue types would be global.
Therefore, to test our hypothesis, we elected to focus on vascular ECs. We chose ECs because
they secrete angiocrine factors which support and sustain homeostasis and regeneration of non-
endothelial stem and progenitor cells after tissue injury and during repair[29]. This should osten-
sibly include adaptation to SBR, an assumption supported by the fact that EC-derived angiocrine
signals are necessary for resection-associated regeneration of the liver and lung[30, 31].
No prior studies have tested whether EGFR signaling in vascular ECs significantly contrib-
utes to resection-induced adaptation and/or angiogenesis. Given that intestinal hypoxia is
associated with massive SBR, the aim of this study was to determine the contribution of epithe-
lial as well as endothelial EGFR and HIF1α activity and expression to structural adaptation,
angiogenesis, and regulation of resection-induced blood flow to the remnant bowel.
Materials and methods
We believed that EGFR is essential for angiogenesis and, therefore, ablated it in the epithelium
and endothelium using Villin-creER and Tie2-creER transgenic mice crossed with an EGFR
(flox/flox) line. Given the role of HIF1α in angiogenesis, we also ablated it the epithelium,
ostensibly the most hypoxic element. Using these mice, we first determined the effects of these
genetic manipulations on intestinal blood flow after SBR. In another set of experiments, we
determined the effect of these genetic manipulations on intestinal adaptation and angiogenic
responses. Then, given that ECs require a stromal support cell for efficient vascularization, we
ablated EGFR expression in intestinal subepithelial myofibroblasts using lentiviral silencing to
determine its effects on vascularization in a microfluidic model of human small intestine[32].
Animals
The Washington University Animal Studies Committee, which is an animal ethics committee
that consists of experts at our institution, reviewed and approved the protocol for this study (Pro-
tocol #20170252) in accordance with the National Institute of Health and laboratory animal care
use and guidelines. All mice underwent a proximal SBR, as described below. C57BL/6J andHyp-
oxia-Inducible Factor 1-alpha (HIF1α)(flox/flox)mice were purchased from the Jackson labora-
tory, while Epidermal growth factor receptor-floxed (Egfrtm1Dwt) mice were generously provided
by David Threadgill (University of North Carolina, Chapel Hill). Villin CreER mice were obtained
via a generous donation from Dr. Sylvie Robine (Curie Institute, Paris, France) and Tie-2-CreER
mice were created by in vitro fertilization of C57BL/6J (Washington University Mouse Genetics
Core, DDRCC, St. Louis, MO). Intestinal epithelial-specific knockout (KO) mice were generated
by crossing Villin CreER mice with Epithelial Growth Factor Receptor (EGFR)(flox/flox) andHyp-
oxia-Inducible Factor 1-alpha (HIF1α)(flox/flox). While endothelial specific KO mice were gener-
ated by crossing Tie-2-CreER mice with Epithelial Growth Factor Receptor (EGFR)(flox/flox).
Wild type (WT) littermates Villin CreER(-) or Tie-2-creER(-) and C57BL/6J were used as
controls. Mutant mice were maintained on a C57BL/6J background. Both male and female
mice were used for SBR experiments. Tamoxifen (Sigma, St. Louis MO) was injected at
1.25mg/25g body weight for 3 consecutive days to induce deletion of gene expression in the
intestinal epithelial specific-KO mice (Villin CreER), while the endothelial specific-KO mice
(Tie-2-creER) received 3.75mg/25g bodyweight for 7 consecutive days[33]. Mice were kept in
the animal holding area with a 12-hour light-dark cycle and given rodent chow ad lib after
weaning. Mice were then given a liquid rodent diet (Micro-Stabilized Rodent Liquid Diet
PLOS ONE EGFR & HIF1α are dispensable for intestinal angiogenesis
PLOS ONE | https://doi.org/10.1371/journal.pone.0236964 September 15, 2020 3 / 19
LD101; Purina Mills, St. Louis, MO) 1–2 days prior to surgery. The average weight for each
mouse line at operation for the immunohistochemistry experiments was obtained (VillinC-
reER(+/-)HIF1α(flox/flox)WT-21.3gm, KO-19.4gm; VillinCreER(+/-)EGFR(flox/flox)WT-
21.3gm, KO-19.0gm; Tie2CreER(+/-)EGFR(flox/flox)WT-20.6gm, KO-18.5gm). At harvest,
mice were euthanatized using a ketamine injection with cervical dislocation.
Operative technique
Mice aged 8–10 weeks underwent 50% proximal SBR as we have previously described[34].
Anesthesia was provided using 0.25% Marcaine injection (2mg/kg) subcutaneously. Briefly,
mice underwent small bowel transection at a point 12cm proximal to the cecum and also at a
point 1-2cm distal to the ligament of Treitz. The mesentery was ligated with 3–0 silk and the
intervening bowel was removed. Intestinal continuity was achieved by re-anastomosis of the
bowel with 9–0 monofilament suture. In the immediate 24-hour post-operative period, the
mice were given water ad libitum. They were then restarted on liquid rodent diet. Mice were
monitored every 12 hours for two days postoperatively and then daily after by assessing water
and food intake as well as physical signs of distress.
Confirmation of enterocyte and endothelial cell gene knockout
Small intestine mucosa was first isolated from Villin CreER(+/-)EGFR and Villin CreER(+/-)
HIF1αmouse lines as previously described[35]. EGFR and HIF1α deficiency were then con-
firmed via RT-PCR using total RNA extracted from enterocytes. For endothelial specific EGFR
deficiency confirmation in the Tie-2-CreER(+/-)EGFR(flox/flox)mouse line, lung endothelial
cells were used to verify the efficiency of gene ablation as previously described[36]. In brief,
lung tissue was harvested and enzymatically digested (2mg/mL Collagenase I (Gibco 17100–
017)) in Live Cell Imaging Solution (Invitrogen, A14291DJ) in a GentleMACS dissociator.
Homogenates were filtered to remove undigested tissue and resuspended. Endothelial cells
were then isolated from this lung cell suspension using CD146 MicroBeads (#130-092-007) and
a MS Column (Miltenyi Biotec, Auburn, CA). Subsequently, total RNA was extracted from iso-
lated endothelial cells and EGFR deficiency was verified via RT-PCR as detailed below.
Measurement of structural adaptation
Formalin-fixed specimens of distal intestine (2cm in length, 2cm from anastomosis) were
embedded into paraffin and then cut into longitudinal 5μm-sections. Villus height, the length
from the tip of the villi to the crypt-villi junction, was measured using H&E stained sections by
a single investigator blinded to mouse strain (NIS elements AR 4; Nikon, Melville, NY). A
minimum of twenty crypts and villi were counted from 2cm intraoperative (IO) segments
proximal to the anastomosis and compared with measurements from the distal remnant ileum
on post-operative day (POD) 7. Adaptation was defined as a 15% increase in villus height and
only mice that demonstrated adaptive villus growth were included in further analysis.
Quantification of intestinal epithelial proliferation and submucosal
capillary density
After tissue sections were formalin-fixed, paraffin-embedded, and sectioned, they were depar-
affinized and blocked with 3% hydrogen peroxide in methanol. Antigen retrieval was per-
formed using Diva Decloaking solution (Biocare Medical, Concord, CA) in a high-pressure
cooker (120˚C for 2 minutes). Slides were blocked with avidin-pink and biotin-blue (Biocare
Medical, Concord, CA), and incubated with either anti-p-histone H3 antibody (#9701, 1:400;
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Cell Signaling Technology, Danvers MA) for proliferation or anti-CD31 antibody (#77699,
1:400; Cell Signaling Technology, Danvers MA) as a marker of angiogenesis in DaVinci Green
(Biocare Technology, Concord, CA) overnight at 4˚C. These were then visualized with biotiny-
lated goat anti-rabbit IgG (Jackson ImmunoResearch Inc. West Grove, PA) followed by strep-
tavidin-horseradish peroxidase (Jackson ImmunoResearch Inc. West Grove, PA),
diaminobenzidine (Sigma-Aldrich, St. Louis, MO), and hematoxylin counterstaining.
As previously described, under light microscopy at 40x magnification, crypt enterocytes
undergoing mitosis that were p-histone H3-stained were counted to assess for proliferation[37].
At least fifteen well-oriented fields of IO and POD7 samples per animal were counted by an
investigator blinded to mouse strain. CD31-stained submucosal microvessels were also counted
at 40x magnification to assess for blood vessel growth, as previously described[38]. At least ten
well-oriented fields of IO and POD7 samples per animal were counted by an investigator blinded
to mouse strain. Percentage change was calculated by matched mouse counts from IO to POD7.
Intestinal sO2 and blood flow measurement by optical-resolution
photoacoustic microscopy
PAM was performed prior to resection (pre-op), immediately after resection, and on POD3 as
we have previously reported[16]. The variables measured included vessel diameter and density,
blood flux, oxygen saturation of hemoglobin (sO2) within the terminal mesenteric arteriole
and the accompanying vein at 6cm proximal to the ileocecal junction on the serosal surface of
the intestine. To measure the sO2 level and flow of red blood cells (RBCs) in the intestinal
blood vessels, we used our previously developed OR-PAM (Fig 1)[39].
Briefly, to calculate sO2, the system consisted of the two short pulse lasers to excite photoa-
coustic wave with two different wavelengths (InnoSlab, Edgewave, for 559 nm, and SPOT-10-
200-532, Elfolight, for 532 nm). During imaging, each laser beam sequentially irradiated the
target at 10 kHz. To detect the PA signal, the system employed a focused ultrasonic transducer
with a 50 MHz central frequency (V214-BB-RM, Olympus). To acquire three-dimensional
images, the system used two motorized translational stages, which enabled two-dimensional
raster scanning. The step sizes for imaging were 2.5μm along the fast axis and 5μm along the
slow axis. Imaging a 4mm by 4mm area took approximately 10 minutes. By taking advantage
of the distinct difference of the optical absorption spectrum of the two forms of hemoglobin,
oxygenated hemoglobin (HbO2) and deoxygenated hemoglobin (HbR), the relative concentra-
tion, hence sO2, can be calculated based on the PA signals acquired with at least two wave-
lengths[40]. In our system, wavelengths of 532nm and 559nm were used. To measure the flow
of RBCs, the bandwidth broadening method was used[41, 42]. Using the wavelength of
532nm, 4000 A-lines were acquired at 10 kHz with M-Mode. By acquiring PA signals at multi-
ple points across a blood vessel, a profile of the flow speed across the vessel as well as the vessel
diameter can be measured. Based on the vessel diameter and the profile of the flow speed, the
volumetric flow of blood per unit time (flux) can be calculated. Based on the measured two-
dimensional sO2 images of the intestinal blood vessels, the oxygen extraction fraction (OEF)
was calculated. A pair of primary artery and vein was first selected within the field of view,
then, the average values of sO2 along the selected artery and vein were calculated. OEF was
then calculated using the following equation: (sO2 in artery − sO2 in vein)/(sO2 in artery). Dur-
ing the measurement, the mice were under inhalational anesthesia with 1.5% isoflurane (Iso-
thesia) and placed on a heating pad with a temperature control.
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Myofibroblast-derived EGFR effects on angiogenesis in a microfluidic
model of human small intestine
Transwell and microfluidic co-culture. All experiments involving human tissues were
carried out in accordance with protocols approved by the Washington University Human
Research Protection Office (HRPO). Endothelial Colony Forming Cell-derived Endothelial
Cells were isolated from de-identified samples of umbilical cord blood as previously described
[43]. Human small intestine subepithelial myofibroblasts (ISEMFs) were isolated from fully
deidentified surgical patients providing informed written consent, which is also witnessed and
Fig 1. Schematic of optical-resolution photoacoustic microscopy (OR-PAM) for in vivo imaging of sO2 and flux of the intestinal blood
vessels. AL, acoustic lens; CL, correction lens; M, mirror; NC, nose cone; OL, objective lens; RAP, right-angle prism; RP, rhomboid prism; SMF,
single-mode fiber; UT, ultrasonic transducer.
https://doi.org/10.1371/journal.pone.0236964.g001
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signed by the witness (Washington University Protocol 201504100, Dr. Deborah C. Rubin).
All aspects of the study, including co-culture of multiple deidentified patient tissues, were per-
formed according to Washington University protocol 201610114.
Co-culture experiments in transwell plates and microfluidic devices were performed as pre-
viously described[44]. After expansion and confirmation of EC and myofibroblast identities
via RT-PCR, cells were co-cultured in a transwell or microfluidic device. Transwell co-cultures
were performed using a 24-well polyester membrane insert with 0.4μm pore size (3450,
Corning).
Microfluidic devices were fashioned as previously described[44]. In brief, devices were fab-
ricated using a SYLGARD 184 Silicone Elastomer Kit (NC9285739, Dow Corning; Midland,
MI) at a 10:1 PDMS curing agent ratio, plasma bonded to glass slides, and sterilized by auto-
clave and exposure to UV light overnight. The devices were then loaded with ECs and ISEMFs
in a 1:1 ratio into the devices’ central chambers and media lines were loaded with EGM-2
media (CC-3162, Lonza; Basel, Switzerland). Media was changed daily. It has been previously
confirmed that ECs alone do not form perfused capillary networks in the microfluidic device
and that ISEMFs are part of the capillary network scaffolding[45]. All cultures were performed
in a 5% oxygen, 5% CO2 incubator.
Lentiviral fluorescent protein transfections. In accordance with Washington University
protocol (#2947), HEK293T was transduced using a three helper plasmid vectors (Addgene
pMDLg-pRRE (Plasmid #12251), Addgene pRSV-Rev (Plasmid #12253), Addgene pMD2.G
(Plasmid #12259)) and a third-generation lentiviral vector (Addgene pLV-Azurite, Plasmid
#36086) to generate an azurite fluorescent protein lentiviral plasmid. Plasmid titers were
added to ECs cultured in EGM-2 media with polybrene (5ug/ml) for 24–48 hours, with confir-
mation by fluorescent microscopy of a 50–90% stable transfection rate. Devices were imaged
using inverted fluorescent microscopy (Olympus IX83 microscope, Olympus; Tokyo, Japan)
with MetaMorph software (Molecular Devices; San Jose, CA).
Quantification of angiogenesis. Expansion of the of the fluorescent EC population was
assessed in Image J (National Institutes of Health; Bethesda, MD). Number of junctions
throughout the microfluidic device were manually counted per high power field. Vessel length
is determined by junction to junction point, and was averaged over the microfluidic device
(in μm per high power field).
EGFR silencing in intestinal subepithelial myofibroblasts. EGFR silencing in ISEMFs
was accomplished using shRNA lentiviral particles and appropriate controls, per manufacturer
protocol, in culture media supplemented with 5μg per ml polybrene (sc-44340-V, sc-108080,
sc-108084, polybrene sc-134220, all Santa Cruz Biotechnology; Dallas, TX). EGFR mRNA and
protein expression were tested one passage after the passage used in co-culture, confirming
stability of the knockout for the duration of co-culture.
RT-PCR
Isolated epithelial and endothelial cell RNA (RNeasy Mini Kit, Qiagen, Germantown, MD)
and ISEMF RNA (Total RNA Purification Kit, 37500, Norgen, Thorold, ON) was extracted
and its concentration determined using a NanoDrop Spectrophotometer (ND-1000; Nano-
Drop Technologies, Wilmington, DE). mRNA expression of EGFR (Hs01076090_m1, Applied
Biosystems, Foster City, CA) and HIF1α (Mm01283757_m1, Applied Biosystems, Foster City,
CA) were determined using Applied Biosystems 7500 Fast Real-Time PCR system with β-actin
as the endogenous control (Mm04394036_g1, Applied Biosystems, Foster City, CA).
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Western blotting
After rinsing with Dulbecco’s Phosphate Buffered Saline (DPBS, 14040, Gibco), protein was
isolated from cultured SIMF cells by lysing with sodium dodecyl sulfate sample buffer (50
mmol/L Tris-HCL, pH 6.8, 2% sodium dodecyl sulfate, 10% glycerol, and 5% 2-mercaptoetha-
nol). Lysate was heated at 100˚C and stored at -20˚C prior to use. Protein concentration was
measured using the RC DC (reducing agent and detergent compatible) Protein Assay Kit II
(5000122, Bio-Rad; Hercules, CA). Proteins were loaded at equal concentrations, and detection
was performed using the Bio-Rad ChemiDoc XRS+ system and image Lab software (Bio-Rad).
Antibodies used were Anti-EGFR (06–847, 1:2500 Millipore; Burlington, MA), Anti-Phospho
EGFR (2234, 1:1000, Cell Signaling Technologies; Danvers, MA), and Anti-Actin (4970S, Cell
Signaling Technologies, 1:10000).
Statistics
Statistical analysis was performed using GraphPad-Prism 7 software (La Jolla, CA). Differences
were assessed using a two-way ANOVA with Tukey’s multiple comparison tests between
groups with mouse lines or using the unpaired Student’s t test and one-way ANOVA for com-
piled PAM results. A p value of<0.05 was considered significant. Graphs with error bars rep-
resent mean + SEM.
Results
Confirmation of EGFR and HIF1α deficiency
The efficiency of EFGR and HIF1α ablation in enterocytes from mutant mice was confirmed
with RT-PCR (Fig 2A and 2B). Similarly, RT-PCR of RNA isolated from endothelial cells in
Tie-2-CreER(+/-)EGFR(flox/flox) confirmed EGFR mRNA was significantly decreased in the
KO mice; however the deletion efficiency is not as high as in enterocytes, which may be due to
different promoter activity or slower endothelium turnover rates (Fig 2B).
Structural adaptation
Intestinal mucosal structural adaptation was demonstrated by percent change in villus growth
from paired intraoperative controls. Equivalent degrees of morphological adaptation were
observed between WT and KO mice after SBR in VillinCreER(+/-)HIFα(flox/flox) (WT—25.8
+/-1.9, KO -26.2+/-5.0, VillinCreER(+/-)EGFR(flox/flox) (WT—28.3+/-3.3, KO—20.8+/-2.0),
and Tie-2-CreER(+/-)EGFR(flox/flox) (WT—26.0+/-3.4, KO—25.4+/-2.9) mouse lines (Fig 2C).
Intestinal epithelial proliferation
Crypt proliferation was measured by immunostaining for phosphorylated histone H3. There
were equivalent degrees of enhanced proliferation between WT and KO mice POD7 after SBR
compared to matched control IO samples in VillinCreER(+/-)HIFα(flox/flox) (WT—23.9+/-4.2,
KO—19.2+/-3.2, VillinCreER(+/-)EGFR(flox/flox) (WT—30.8+/-6.3, KO—27.1+/-6.2), and
Tie-2-CreER(+/-)EGFR(flox/flox)(WT—30.3+/-6.1, KO—34.3+/-7.1) mouse lines (Fig 3A).
Submucosal capillary density
The percentage change in submucosal capillary density was equivalent between WT and KO
mice after SBR in VillinCreER(+/-)HIFα(flox/flox) (WT—8.6+/-7.0, KO—6.1+/-9.8, VillinC-
reER(+/-)EGFR(flox/flox) (WT—11.2+/-8.7, KO—42.12+/-15.1), and Tie-2-CreER(+/-)EGFR
(flox/flox) (WT—14.4+/-7.0, KO—18.1+/-9.1) mouse lines (Fig 3B).
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Fig 3. Changes in crypt proliferation and submucosal capillary density. (A) Percentage change in crypt proliferation from IO to POD7 in VillinCreER(+/-)
HIF1α(flox/flox)WT (n = 7) and KO (n = 7) mice, VillinCreER(+/-)EGFR(flox/flox)WT (n = 7) and KO (n = 8) mice, and Tie2CreER(+/-)EGFR(flox/flox)WT
(n = 6) and KO (n = 5) mice. (B) Percentage change in submucosal capillary density from IO to POD7 in VillinCreER(+/-)HIF1α(flox/flox)WT (n = 7) and KO
(n = 7) mice, VillinCreER(+/-)EGFR(flox/flox)WT (n = 7) and KO (n = 8) mice, and Tie2CreER(+/-)EGFR(flox/flox)WT (n = 5) and KO (n = 5) mice.
https://doi.org/10.1371/journal.pone.0236964.g003
Fig 2. Knockout confirmation and structural adaptation. (A) Enterocyte HIF1α expression in VillinCreER(+/-)HIF1α(flox/flox)WT (n = 7) and KO (n = 7)
mice. (B) Enterocyte EGFR expression in VillinCreER(+/-)EGFR(flox/flox)WT (n = 6) and KO (n = 8) mice and lung endothelial cell EGFR expression in
Tie2CreER(+/-)EGFR(flox/flox)WT (n = 2) and KO (n = 2) mice. (C) Percent change in villus height from IO to POD7 in VillinCre(+/-)HIFα (WT n = 7, KO
n = 7), VillinCreER(+/-)EGFR(flox/flox) (WT n = 7, KO n = 8), and Tie-2-CreER(+/-)EGFR(flox/flox) (WT n = 6, KO n = 5) mouse lines after SBR.
https://doi.org/10.1371/journal.pone.0236964.g002
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Intestinal sO2 and blood flow measurement
Fig 4A and 4B demonstrate representative 2D sO2 images, which are based on the PA images
before and immediately after SBR. The sO2 in the main vein visually clearly dropped, suggest-
ing a rapid immediate increase of the OEF.
This hemodynamic response was observed in all mice, regardless of mouse line, with a sig-
nificant 88% increase in OEF (Fig 5C). In addition, this response is associated with a signifi-
cant drop in the arterial and venous blood flow rates immediately after SBR (represented in
Fig 4C–4F), by 25% and 52%, respectively (Fig 5A and 5B). In addition, venous flow rate con-
tinues to remain diminished until POD3 (Fig 5B). OEF, after immediate rapid increase, signifi-
cantly decreased by 57% on POD3 (Fig 5C).
However, when divided by genotype, time has a statistically significant effect on the mea-
sured venous flux and OEF but not arterial flux. EGFR deficiency in epithelial and endothelial
cells and HIF1α deficiency in epithelial cells do not affect arterial blood flow, venous blood
flow, or OEF (Fig 6A–6C and Table 1).
Expression of EGFR in stromal ISEMFs is dispensable to small intestinal
angiogenesis
Thus far, our results have demonstrated no effect on epithelial HIF1α KO or EGFR KO in
either epithelium or endothelium on SBR induced angiogenesis. This led us to explore one
alternative source of EGFR signaling during angiogenesis–SI stromal cells. We chose to
explore this because we have previously demonstrated that ISEMFs are necessary for EC capil-
lary development in an ex vivomicrofluidic culture system[44]. We interrogated the role of
ISEMF EGFR by performing ISEMF and EC co-culture experiments (Fig 7A). This revealed a
moderate but insignificant increase in EGFR mRNA expression in both ISEMFs and ECs
when cultured in the presence of one another (Fig 7B). However, we were only able to detect
EGFR protein expression in ISEMFs (Fig 7C). Thus, we subsequently performed shRNA
knockout of EGFR in ISEMFs to determine whether angiogenesis would still be affected.
Silencing of EGFR in ISEMFs was confirmed using quantitative RT-PCR for mRNA (Fig 7D,
upper panel), and western blot for protein expression (Fig 7D, lower panel). Subsequently,
ISEMFs transduced with EGFR shRNA were co-cultured with fluorescently labeled ECs in
microfluidic devices for 7 days. Silencing of EGFR in ISEMFs did not inhibit vessel network
formation in this system, qualitatively and quantitatively (Fig 7F–7G). This led us to conclude
that EGFR expression in at least three cell types (epithelium, endothelium, and ISEMFs) is dis-
pensable to intestinal angiogenesis.
Discussion
Massive small bowel resection results in abrupt reductions in blood flow to the remnant bowel
with elevated levels of HIF1α, a compensatory increase in villus height, and corresponding
angiogenesis[9, 17]. Our goal in this study was to determine if EGFR or HIF1α signaling in the
epithelium or the endothelium, are required for resection-associated hemodynamic responses,
intestinal adaptation, and angiogenesis.
We have previously shown through PAM, that there is a significant fall in oxygen saturation
and blood flow within the remnant bowel immediately after SBR in vivo[16]. This was repli-
cated in our conglomerated data, with a significant fall in arterial and venous blood flow with a
corresponding increased demand in tissue oxygen extraction immediately after resection. The
immediate decrease in blood flow likely results from the acute ligation of the mesenteric vascu-
lature. Interestingly, by POD3, venous blood flow remained significantly reduced, but both
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Fig 4. Representative sO2 images of intestinal blood vessels and blood flow profiles of the intestinal artery and vein. (A) sO2 image before SBR. (B) sO2
image after SBR. (C) Blood flow profile of the artery before SBR. (D) Blood flow profile of the vein before SBR. (E) Blood flow profile of the artery immediately
after SBR. (F) Blood flow profile of the vein immediately after SBR. Blue circles represent the measured data, and the dashed red lines represent the fitting curve
of the quadratic function in (C) to (F).
https://doi.org/10.1371/journal.pone.0236964.g004
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arterial blood flow and oxygen saturation returned to baseline pre-operative values. Therefore,
we posit that this is a hypoxic signal to stimulate angiogenesis and return of arterial blood flow
to its normal preoperative state. However, this angiogenic signal does not affect the reestablish-
ment of baseline venous blood flow by POD3. We believe that this may be due to angiogenic
signals after SBR acting preferentially on arterial vessels, as it has been shown that arterial and
venous endothelial cells are molecularly distinct with varying expressions of receptors and
ligands involved in angiogenesis[46, 47]. The findings of arterial flow normalizing while
venous blood flow remains diminished in the early postoperative state have previously been
shown, implying that arterial blood flow responds more quickly to resection than venous
blood flow[48].
Given the PAM study results, we focused on the attenuation of two key regulators of angio-
genesis, HIF1α in the epithelium, and EGFR in the epithelium and endothelium, to determine
if they could be the driver of signaling to return arterial blood flow to baseline after resection.
We discovered that no genetic alteration affected arterial or venous blood flow and resulting
tissue oxygen extraction by POD3. Additionally, we have shown that there is also no change in
submucosal capillary density, a marker of angiogenesis, as well as adaptation, with loss of these
proteins by POD7. Although prior work has found that inhibition of angiogenesis by selective
Fig 5. Ungrouped measurements of the hemodynamic response of OEF, with blood flow. (A) Ungrouped results of the arterial blood flow; �p<0.05,
ANOVA ns. (B) Ungrouped results of the venous blood flow; ����p<0.0001, ANOVA p<0.0001. (C) Ungrouped results of OEF; ����p<0.0001, ANOVA
p<0.0001.
https://doi.org/10.1371/journal.pone.0236964.g005
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Fig 6. The hemodynamic response of (A) arterial blood flow, (B) venous blood flow, and (C) OEF for each operative group (n = 6–9) at pre-operative,
immediate, and POD3 timepoints.
https://doi.org/10.1371/journal.pone.0236964.g006
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blockade of salivary-derived vascular endothelial growth factor impairs adaptation, this study
provides evidence that neither epithelial nor endothelial EGFR and epithelial HIF1α are dis-
pensable to intestinal angiogenesis[49]. Endothelial cells are certainly responsive to EGFR ago-
nists, as we previously demonstrated that direct treatment of human umbilical vein endothelial
cells with EGF resulted in significantly increased expression of the proangiogenic chemokine
CXCL5[50]. The contribution of CXCL5 to resection-induced intestinal angiogenesis was
demonstrated using CXCL5-null mice, in which angiogenesis was blunted[51]. Although
Table 1. Summary of the significance of the effects of time (pre-op/immediate/POD3), genetic alteration (con-
trol/KO/WT per mouse line), and their interaction on the hemodynamics, which is evaluated by p-values calcu-
lated by 2-way ANOVA.
Arterial flux Venous flux OEF
Time ns <0.0001 <0.0001
Genotype ns ns ns
https://doi.org/10.1371/journal.pone.0236964.t001
Fig 7. EGFR expression and knockout in ISEMFs. (A) Transwell co-culture of ECs and ISEMFs was performed as depicted. (B) After 24h in culture, RNA was
isolated and quantitative RT-PCR performed for EGFR expression (n = 3 per condition). (C) Western blot for EGFR protein expression in ECs and ISEMFs
cultured either alone or together. (D) Expression of EGFR mRNA (upper panel) and protein (lower panel) in ISEMFs transduced with EGFR shRNA lentiviral
particles, with copGFP and shRNA lentiviral controls as indicated. (E) Schematic of microfluidic device system. (F) Representative images of vessel networks
formed in microfluidic devices with fluorescent ECs and ISEMFs transduced with EGFR shRNA silencing (left), as opposed to copGFP (middle) and shRNA
(right) lentiviral controls. (G) Quantitative analysis of vessel networks with number of junctions per high power field and average vessel length in microfluidic
devices with fluorescent ECs and ISEMFs transduced with EGFR shRNA silencing (n = 4,3), copGFP (n = 6,3), and shRNA (n = 1,1) lentiviral controls,
respectively.
https://doi.org/10.1371/journal.pone.0236964.g007
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EGFR inhibition has been shown to attenuate intestinal adaptation, we have shown that inhibi-
tion in the epithelium and endothelium does not affect angiogenesis[52–54]. This suggests that
angiogenesis and adaptation are uncoupled responses to massive intestinal resection.
From this data, we then hypothesized that another submucosal cell type, stromal myofibro-
blasts, might be contributing to angiogenesis by recovering the loss of EGFR ablation in ECs
or enterocytes. Based on literature that ISEMFs are critical to intestinal cell lineage develop-
ment, we hypothesized that ISEMFs integrate environmental stimuli to direct angiogenesis[55,
56]. We have shown that patient-derived ISEMFs have angiogenic properties and form a vas-
cular network when co-cultured with ECs in microfluidic devices. Additionally, we have
shown that inhibition with Erlotinib, a receptor tyrosine kinase inhibitor of EGFR, prevents
vasculogenesis in these co-cultures[44]. Given these prior findings, and the fact that we have
shown that EGFR was strongly expressed in ISEMFs, we used this ex vivomicrofluidic model
of human small intestine to study the effects of EGFR signaling from ISEMFs on ECs. We
found that silencing of SIMF EGFR did not prevent capillary network formation, leading us to
conclude either that Erlotinib may be exhibiting off-target effects to inhibit angiogenesis, inde-
pendent of EGFR, or that there are other EGFR-responsive cell types that contribute to adap-
tive angiogenesis[57].
Despite ablating EGFR in three cell lines, including enterocytes, ECs, and ISEMFs, there
was no significant impact on angiogenesis after massive SBR. A limitation of this study
includes the small sample size, commonly seen in animal studies, and partial deletion of EGFR
in EC cells; we only confirmed EGFR deficiency in representative samples. We cannot con-
clude that EGFR is dispensable to SI angiogenesis in all situations, as several groups have
described that EGFR, and especially endothelial EGFR, becomes conditionally activated or
expressed during times of challenge such as hypoxia, toxicity, or malignancy[58–61]. Addi-
tionally, despite showing increased intestinal expression of HIF1α after SBR, epithelial HIF1α
expression was dispensable to angiogenesis by POD7[62]. We now hypothesize that circulating
humoral factors after SBR, which have been shown to induce SI adaptation, are accounting for
the lack of impact on angiogenesis after these selective cell line ablations[63, 64].
Conclusion
Overall, despite the importance of EGFR in facilitating intestinal adaptation after SBR, it had
no impact on angiogenesis in three cell types–enterocytes, ECs, and ISEMFs. Despite the initial
increase in HIF1α expression after SBR as well as immediate increase in demand in oxygen
extraction fraction via PAM, epithelial ablation of HIF1α had no impact on angiogenesis in
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